SABCS 2022 Conference Coverage
Playback speed
10 seconds
SABCS 2022 TROPiCS-02 Phase 3 Study of Patients With HR+/HER2- mBC: Sacituzumab Govitecan vs. Treatment of Physician’s Choice - Efficacy by Trop-2 Expression
By
SABCS 2022 Conference Coverage
FEATURING
Hope Rugo
By
SABCS 2022 Conference Coverage
FEATURING
Hope Rugo
172 views
December 23, 2022
Comments 0
Login to view comments.
Click here to Login
Videos